In this webinar, Certara expert, Anaya Rehman will talk through the changes and lessons learned nearly 6 months after CTIS was implemented. They’ll share first impressions, talk through some of the biggest challenges to date and share what next steps sponsors should take to continue to prepare for the challenges that still lie ahead.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at [ Ссылка ]
